Antibody

383개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved383 programs
AntibodyLimited DatastaleNYU Langone HealthPhase 2

belimumab (belimumab)

Rheumatic Disease · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 51Status Recruiting
AntibodyLimited DatastaleWei-Che KoPhase 3

Sarilumab (Sarilumab)

Skin Inflammation; Allergic Contact Dermatitis · Melanoma

#Melanoma#Antibody#Phase3#Popular#monoclonal-antibody+4
Trials 50Status Recruiting
AntibodyLimited DatastaleXuekui LiuPhase 2

Zimberelimab (Zimberelimab)

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable · Prostatic Neoplasms, Castration-Resistan

#ProstaticNeoplasmsCastration-Res#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 50Status Recruiting
AntibodyCurated CorestaleEpizyme, Inc.Phase 3

Mosunetuzumab (Mosunetuzumab)

Relapsed Hematologic Malignancy; Refractory Hematologic Malignancy · FRα

#FR#Antibody#Phase3#BioJungboMoa-pick#monoclonal-antibody+4
Trials 49Status Recruiting
AntibodyLimited DatastaleMridula George, MDPhase 2

Retifanlimab (Retifanlimab)

Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Breast Carcinoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#monoclonal-antibody#AnatomicStageIVBreastCancerAJCCv+3
Trials 49Status Recruiting
AntibodyLimited DatastaleBristol-Myers SquibbPhase 2

Belatacept (Belatacept)

Highly Sensitized Prospective Kidney Transplant Recipients · Kidney Transplantation

#KidneyTransplantation#Antibody#Phase2#monoclonal-antibody#HighlySensitizedProspectiveKidne+2
Trials 48Status Active
AntibodyLimited DatastaleEpizyme, Inc.Phase 2

Tafasitamab (Tafasitamab)

Relapsed Hematologic Malignancy; Refractory Hematologic Malignancy · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#monoclonal-antibody#RelapsedHematologicMalignancy+3
Trials 48Status Discontinued
AntibodyLimited DatastaleChia Tai Tianqing Pharmaceutica…Phase 2

Penpulimab (Penpulimab)

Advanced Malignant Neoplasm · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#AdvancedMalignantNeoplasm+2
Trials 47Status Active
AntibodyLimited DatastaleNew Approaches to Neuroblastoma…Phase 1

Dinutuximab (Dinutuximab)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#Antibody#Phase1#monoclonal-antibody#NKcellsbyacombinatorialimmunothe+1
Trials 44Status Recruiting
AntibodyLimited DatastaleRochePhase 3

Ocrelizumab, Rituximab, Ofatumumab (Anti-CD20 therapies, Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab))

Relapsing-Remitting Multiple Sclerosis (RRMS); Anti-CD20 Therapy · CD20

#CD20#Antibody#Phase3#monoclonal-antibody#Relapsing-RemittingMultipleScler+3
Trials 40Status Recruiting
AntibodyCurated CorestaleJanssenPhase 3

Talquetamab (Talquetamab)

Myeloma Multiple; Plasma Cell Leukemia · FRα

#FR#Antibody#Phase3#BioJungboMoa-pick#monoclonal-antibody+4
Trials 40Status Discontinued
AntibodyLimited DatastaleSanofiPhase 3

Isatuximab SAR650984 (Isatuximab SAR650984)

Immune System Disorder · Plasma Cell Myeloma

#PlasmaCellMyeloma#Antibody#Phase3#monoclonal-antibody#ImmuneSystemDisorder+2
Trials 39Status Active
AntibodyLimited DatastaleHoffmann-La RochePhase 2

Hu5F9-G4 (Magrolimab, Magrolimab (Hu5F9-G4))

Urothelial Carcinoma; Bladder Cancer · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Phase2#monoclonal-antibody#BladderCancer+2
Trials 35Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Ipilimumab plus nivolumab)

Melanoma; Non Small Cell Lung Cancer · Melanoma

#Melanoma#Antibody#Phase2#monoclonal-antibody#NonSmallCellLungCancer+1
Trials 32Status Recruiting
AntibodyLimited DatastaleMerck Sharp & Dohme LLCPhase 3

H1 receptor antagonist (H1 receptor antagonist)

Ovarian Cancer; Fallopian Tube Cancer · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Phase3#monoclonal-antibody#OvarianCancer+3
Trials 31Status Recruiting
AntibodyLimited DatastaleMerck Sharp & Dohme LLCPhase 3

H2 receptor antagonist (H2 receptor antagonist)

Ovarian Cancer; Fallopian Tube Cancer · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Phase3#monoclonal-antibody#OvarianCancer+2
Trials 31Status Recruiting
AntibodyLimited DatastaleRochePhase 3

atezolizumab (Tecentriq, Tiragolumab and Atezolizumab)

Head and Neck Neoplasms; MSI-H Cancer · Cancer

#Cancer#Antibody#Phase3#monoclonal-antibody#HeadandNeckNeoplasms+3
Trials 31Status Recruiting
AntibodyLimited DatastaleQuantumLeap Healthcare Collabor…Phase 2

AMG 479 (AMG 479, Ganitumab, AMG 479 (Ganitumab) plus Metformin)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+3
Trials 30Status Recruiting
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, HER2, pyrotinib + pertuzumab/trastuzumab)

Salivary Gland Carcinoma; Precision Therapy · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#SalivaryGlandCarcinoma+2
Trials 30Status Recruiting
AntibodyLimited DatastaleGrupo Español de Linfomas y Tra…Phase 2

Zevalin (Ibritumomab Tiuxetan, Ibritumomab Tiuxetan (Zevalin))

Non-Hodgkin Lymphoma · Lymphoma

#Lymphoma#Antibody#Phase2#monoclonal-antibody#Non-HodgkinLymphoma+1
Trials 30Status Active

3 / 20 pages

← PreviousNext →